Resistance of Prostate Cancer Cells to Soluble TNF-related Apoptosis-Inducing Ligand (TRAIL/Apo2L) Can Be Overcome by Doxorubicin or Adenoviral Delivery of Full-Length TRAIL
Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700420
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2002
Authors
Publisher
Springer Science and Business Media LLC